BOSTON--(BUSINESS WIRE)--pSivida Corp, (NASDAQ:PSDV, ASX:PSD, FF:PV33), a leader in the development of ophthalmic sustained release drug delivery products, with two of the only three such products approved by the FDA for treatment of back of the eye diseases, today announced it will be presenting at the Cowen & Company Annual Health Care Conference in Boston, March 8. Dr. Paul Ashton, president and chief executive officer, will present at 4:45 p.m. Eastern time.
